Back HCV Policy & Advocacy

HCV Policy & Advocacy

Advocates Launch Hepatitis Elimination Campaign on World Hepatitis Day

Coinciding with World Hepatitis Day on July 28, global advocates launched a new NOHep initiative to eliminate viral hepatitis -- including life-threatening chronic hepatitis B and C -- by the year 2030. To find out more, visit www.NOhep.org or follow the #NOhep hashtag on Twitter.

alt

Read more:

EASL 2016: Cost of Eliminating Viral Hepatitis Must Consider Social as Well as Medical Factors

Securing commitments from national governments to treat viral hepatitis, scale up prevention activities, and aim for elimination of hepatitis B and C by 2030 will require a broad coalition of forces -- and a sophisticated approach to proving the value of investing in elimination of viral hepatitis -- delegates heard at last month’s EASL International Liver Congress.

alt

Read more:

EASL 2016: Low-Cost Generic Hepatitis C Drugs Match Branded Products in Viral Response

Generic versions of direct-acting antivirals for hepatitis C purchased from China and India by people unable to obtain treatment in their own countries were just as effective and safe as the branded products, a study of 139 patients monitored by Australian doctor James Freeman has shown. The findings were presented in a late-breaking research session at the European Association for the Study of the Liver's International Liver Congress (EASL 2016) in Barcelona on Saturday.

alt

Read more:

EASL 2016: How Generic Direct-Acting Antivirals Are Changing the Hepatitis C Treatment Landscape

The arrival of generic versions of direct-acting antivirals (DAAs) is transforming the global hepatitis C treatment landscape and highlighting the overlooked importance of the cost of monitoring technologies, presenters said at the EASL International Liver Congress (EASL 2016) last week in Barcelona.

alt

Read more:

EASL 2016: Liver Associations Worldwide Call for Elimination of Viral Hepatitis

Leaders of liver disease associations from Europe, the U.S., Latin America, and Asia released a Joint Society Statement on Elimination of Viral Hepatitis at the opening session of the International Liver Congress (EASL 2016) this week in Barcelona, calling for enhanced efforts to diagnose and treat hepatitis B and C, with the goal of eliminating viral hepatitis as a public health threat.

alt

Read more: